German Medical Marijuana Sales To Reach $1.09B By 2028, New Report

New report on Germany’s cannabis market by Prohibition Partners reveals that German medical marijuana sales are projected to reach €420 million euros in 2024 ($260.66 million) reaching €1 billion by 2028. Prohibition Partners is a data, media and tech company operating in the legal cannabis industry providing specialist information and data analytics.

The report comes several months after major cannabis reform in Germany with the implementation of the Cannabis Act (CanG) and the associated MedCanG Act. Partial cannabis legalization took effect in Germany on April 1, allowing people over 18 to legally possess up to 25 grams of dried cannabis and cultivate up to three plants at home. One of the biggest breakthroughs under the law is that medical cannabis is essentially regulated like ibuprofen.

“Germany’s cannabis market is currently at a pivotal point,” stated Alex Khourdaji, senior …

Full story available on Benzinga.com